Literature DB >> 22450148

Larynx preservation.

Jean-Louis Lefebvre1.   

Abstract

PURPOSE OF REVIEW: Organ preservation, in particular larynx preservation, is a major challenge that has been evaluated during the past 3 decades. This review took in consideration the most recently published articles on this topic. RECENT
FINDINGS: There are no new data on this topic but mainly confirming data. Most of the reports underscored that there was still a place for upfront surgery (either partial or total laryngectomy). Nonsurgical approaches are radiotherapy alone or chemotherapy-based protocols with either induction or concomitant chemotherapy added to radiotherapy (with conventional or accelerated fractionation). Different authors underscored that daily practice must follow carefully the selection of patients and monitoring of treatment when applying protocols evaluated in randomized clinical trials.
SUMMARY: Larynx preservation is an undisputable advance in larynx cancer management. For early diseases, either surgery (open or endoscopic) or irradiation may control the disease and preserve the larynx function. For advanced cases, chemotherapy-based protocols have been validated, but the best protocol is still to be defined. Importantly some cases still require upfront total laryngectomy. A multidisciplinary approach for decision making is mandatory, whatever the stage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450148     DOI: 10.1097/CCO.0b013e3283523c95

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  8 in total

1.  Different spectral hounsfield unit curve and high-energy virtual monochromatic image characteristics of squamous cell carcinoma compared with nonossified thyroid cartilage.

Authors:  R Forghani; M Levental; R Gupta; S Lam; N Dadfar; H D Curtin
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-05       Impact factor: 3.825

2.  Function preservation using transoral laser surgery for T2-T3 glottic cancer: oncologic, vocal, and swallowing outcomes.

Authors:  Giorgio Peretti; Cesare Piazza; Francesca Del Bon; Renzo Mora; Paola Grazioli; Diego Barbieri; Stefano Mangili; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

3.  Early Cellular Response to Radiation in Human Vocal Fold Fibroblasts.

Authors:  Elizabeth Erickson-DiRenzo; Gabrielle Enos; Susan L Thibeault
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-11-08       Impact factor: 1.547

Review 4.  Current Role of Total Laryngectomy in the Era of Organ Preservation.

Authors:  Alexandre Bozec; Dorian Culié; Gilles Poissonnet; Olivier Dassonville
Journal:  Cancers (Basel)       Date:  2020-03-03       Impact factor: 6.639

5.  Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.

Authors:  Giannis Mountzios; Ioannis Kostopoulos; Vassiliki Kotoula; Ioanna Sfakianaki; Elena Fountzilas; Konstantinos Markou; Ilias Karasmanis; Sofia Leva; Nikolaos Angouridakis; Konstantinos Vlachtsis; Angelos Nikolaou; Ioannis Konstantinidis; George Fountzilas
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

6.  Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up.

Authors:  V Kouloulias; S Triantopoulou; J Vrouvas; K Gennatas; N Ouzounoglou; J Kouvaris; P Karaiskos; P Aggelakis; C Antypas; A Zygogianni; K Papavasiliou; K Platoni; N Kelekis
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

7.  Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma.

Authors:  Megan L Ludwig; Andrew C Birkeland; Rebecca Hoesli; Paul Swiecicki; Matthew E Spector; J Chad Brenner
Journal:  Cancer Biol Med       Date:  2016-03       Impact factor: 4.248

8.  A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers.

Authors:  Xuan Su; Hui-Chan He; Zu-Lu Ye; Da-Lei Zhou; Qing Liu; Xin-Hua Yang; Ya-Kang Long; Tao Tang; Jiang-Jun Ma; Bo-Heng Xu; Wei-Chao Chen; Cai-Yun He; An-Kui Yang
Journal:  Front Oncol       Date:  2020-10-15       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.